Mitochondrial respiratory chain function in multiple system atrophy

Movement Disorders

Volumn 12, Issue 3, 1997, Pages 418-422

  Gu, M ^a   Gash, M T ^a   Cooper, J M ^a   Wenning, G K ^b   Daniel, S E ^c   Quinn, N P ^b   Marsden, C D ^b   Schapira, A H V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Institute of Neurology   (United Kingdom)

Author keywords

L DOPA; Mitochondria; Multiple system atrophy

Indexed keywords

LEVODOPA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; TISSUE SPECIFICITY;

AGED; ANTIPARKINSON AGENTS; ATROPHY; BLOOD PLATELETS; BRAIN; CITRATE (SI)-SYNTHASE; CULTURE TECHNIQUES; ELECTRON TRANSPORT; HUMANS; LEVODOPA; MIDDLE AGED; MITOCHONDRIA; NERVE DEGENERATION; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0030976374     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120323     Document Type: Article

References (17)

1. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy Drager syndrome). J Neural Sci 1989;94:79-100.
2. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. London: ButterworthHeinemann, 1995:262-81.
3. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondria! complex I deficiency in Parkinson's disease. Lancet 1989;1:1269.
4. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994;169:126-8.
5. Schapira AHV. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov Disord 1994;9: 125-38.
6. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-7.
7. Wharton DC, Tzagoloff A. Cytochrome oxidase from bovine heart mitochondria. Methods Enzymol 1967;10:245-57.
8. Schapira AHV, Mann VM, Cooper JM, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-5.
9. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992; 115: 333-42.
10. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV. Platelet mitochondrial function in Parkinson's disease. Ann Neural 1992:32:782-8.
11. Benecke R, Strümper P, Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndrome. Brain 1993;116:1451-63.
12. Blin O, Desnuelle C, Rascol O, et al. Mitochondria respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125: 95-101.
13. Przedborski S, Jackson-Lewis V, Muthane U, et al. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann Neurol 1993:34:715-23.
14. Mann VM, Cooper JM, Daniel SE, Jenner P, Marsden CD, Schapira AHV. Complex I, iron and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994;36:876-81.
15. Cooper JM, Daniel SE, Marsden CD, Schapira AHV. L-DOPA and complex I deficiency in Parkinson's disease brain. Mov Disord 1995;10:295-7.
16. Bravi D, Anderson JJ, Dagani F, et al. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord 1992;7:228-31.
17. Shults CW, Nasirian F, Ward DM, et al. Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism. Neurology 1995;45:344-8.